Viemed Healthcare Past Earnings Performance
Past criteria checks 3/6
Viemed Healthcare's earnings have been declining at an average annual rate of -6.7%, while the Healthcare industry saw earnings declining at 6.7% annually. Revenues have been growing at an average rate of 17.2% per year. Viemed Healthcare's return on equity is 8.5%, and it has net margins of 5.4%.
Key information
-6.7%
Earnings growth rate
-7.2%
EPS growth rate
Healthcare Industry Growth | -6.7% |
Revenue growth rate | 17.2% |
Return on equity | 8.5% |
Net Margin | 5.4% |
Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Is Viemed Healthcare (TSE:VMD) A Risky Investment?
Sep 13The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence
May 27Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Feb 18Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Oct 27Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital
Jul 08Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?
Mar 10These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well
Dec 09Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why
Jun 04Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt
May 18Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?
Mar 03I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease
Feb 16Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly
Feb 03If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns
Jan 21Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?
Jan 08Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?
Dec 22Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?
Nov 25Revenue & Expenses Breakdown
How Viemed Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 170 | 9 | 86 | 3 |
30 Jun 23 | 156 | 7 | 80 | 3 |
31 Mar 23 | 146 | 6 | 77 | 3 |
31 Dec 22 | 139 | 6 | 73 | 3 |
30 Sep 22 | 133 | 8 | 70 | 3 |
30 Jun 22 | 127 | 9 | 66 | 2 |
31 Mar 22 | 121 | 9 | 61 | 2 |
31 Dec 21 | 117 | 9 | 60 | 2 |
30 Sep 21 | 116 | 10 | 58 | 2 |
30 Jun 21 | 120 | 11 | 58 | 2 |
31 Mar 21 | 136 | 29 | 62 | 1 |
31 Dec 20 | 131 | 32 | 58 | 1 |
30 Sep 20 | 122 | 29 | 55 | 1 |
30 Jun 20 | 108 | 29 | 52 | 1 |
31 Mar 20 | 86 | 11 | 47 | 1 |
31 Dec 19 | 80 | 9 | 45 | 1 |
30 Sep 19 | 76 | 9 | 45 | 1 |
30 Jun 19 | 73 | 8 | 43 | 0 |
31 Mar 19 | 68 | 9 | 39 | 0 |
31 Dec 18 | 64 | 10 | 37 | 0 |
30 Sep 18 | 60 | 7 | 36 | 0 |
30 Jun 18 | 56 | 9 | 31 | 0 |
31 Mar 18 | 51 | 8 | 29 | 0 |
31 Dec 17 | 47 | 8 | 25 | 0 |
30 Sep 17 | 43 | 11 | 17 | 0 |
31 Dec 16 | 31 | 1 | 18 | 0 |
31 Dec 15 | 38 | 10 | 18 | 0 |
31 Dec 14 | 23 | 9 | 10 | 0 |
Quality Earnings: VMD has high quality earnings.
Growing Profit Margin: VMD's current net profit margins (5.4%) are lower than last year (5.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VMD's earnings have declined by 6.7% per year over the past 5 years.
Accelerating Growth: VMD's earnings growth over the past year (16.9%) exceeds its 5-year average (-6.7% per year).
Earnings vs Industry: VMD earnings growth over the past year (16.9%) exceeded the Healthcare industry -0.2%.
Return on Equity
High ROE: VMD's Return on Equity (8.5%) is considered low.